Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...

Want to learn more about Microsoft's family of Copilots? Here's our guide to Copilot and Copilot in Microsoft 365, as well as ...

With a free starter plan ... in creating and managing sales pipelines, a critical component of any sales strategy. With Pipedrive, setting up a custom sales pipeline is straightforward, whether by ...

Slidesgo is an excellent AI presentation maker for those seeking a free and customisable solution. It allows users to quickly generate presentations tailored to their specific needs, offering a wide ...

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's ...

Ipsen expects total sales growth of more than 5% at constant exchange rates in 2025, supported by the continued expansion of products like IQIRVO, ONIVYDE, and Bylvay. However, Somatuline faces ...

Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) fourth-quarter financial report. Vertex reported solid fourth-quarter numbers throughout its business. While the company's ...

The sales pipeline stands at £4.8m, including £3.4m in advanced negotiations. The group anticipates converting a portion of this pipeline during the second half of the financial year ...

Vertex reported solid fourth-quarter numbers throughout its business. While the company's earnings per share came in slightly shy of expectations, top-line revenue growth was a significant beat.

Discover key insights from Basilea Pharmaceutica AG's Q4 2024 earnings call. Learn about robust revenue growth, FDA approvals, and pipeline advancements.

US retail sales slumped in January by the most in nearly two years, indicating an abrupt pullback by consumers after a spending spree in the closing months of 2024. The value of retail purchases ...